Allergan approaches Salix

The Wall Street Journal reported that Allergan Inc. (NYSE: AGN) approached Salix Pharmaceuticals (Nasdaq: SLXP) for a possible acquisition. Shares of Allergan soared $6.21 to close at $161.82 while Salix stock rocketed $21.63 to close at $160.80.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.